149 related articles for article (PubMed ID: 3632148)
1. Reversible adsorption (desorption) of aspirin from activated charcoal.
Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
Curtis RA; Barone J; Giacona N
Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
[TBL] [Abstract][Full Text] [Related]
3. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
Juhl RP
Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
Easom JM; Caraccio TR; Lovejoy FH
Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
[TBL] [Abstract][Full Text] [Related]
5. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion.
Rivera W; Kleinschmidt KC; Velez LI; Shepherd G; Keyes DC
Ann Pharmacother; 2004; 38(7-8):1186-8. PubMed ID: 15173556
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
[TBL] [Abstract][Full Text] [Related]
7. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
Levy G; Soda DM; Lampman TA
Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
[TBL] [Abstract][Full Text] [Related]
9. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
Olsen KM; Ma FH; Ackerman BH; Stull RE
Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
Scholtz EC; Jaffe JM; Colaizzi JL
Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
[No Abstract] [Full Text] [Related]
11. The bioavailability of two beta-blockers preadsorbed onto charcoal.
Roivas L; Ojala-Karlsson P; Neuvonen PJ
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):125-32. PubMed ID: 7911863
[TBL] [Abstract][Full Text] [Related]
12. Enteral exsorption of acetaminophen after intravenous injection in rats: influence of activated charcoal on this clearance path.
Eyer F; Jung N; Neuberger H; Schulz R; Steiner K; Ladstetter B; Poethko T; Henke J; Zilker T
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):163-71. PubMed ID: 17697035
[TBL] [Abstract][Full Text] [Related]
13. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
Sketris IS; Mowry JB; Czajka PA; Anderson WH; Stafford DT
J Clin Pharmacol; 1982 Jan; 22(1):59-64. PubMed ID: 7061727
[TBL] [Abstract][Full Text] [Related]
14. The effect of activated charcoal on the bioavailability of piroxicam in man.
Laufen H; Leitold M
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
[TBL] [Abstract][Full Text] [Related]
15. The adsorption of salicylates by a milk chocolate-charcoal mixture.
Eisen TF; Grbcich PA; Lacouture PG; Shannon MW; Woolf A
Ann Emerg Med; 1991 Feb; 20(2):143-6. PubMed ID: 1996795
[TBL] [Abstract][Full Text] [Related]
16. Effect of activated charcoal administration on acetylcysteine serum levels in humans.
North DS; Peterson RG; Krenzelok EP
Am J Hosp Pharm; 1981 Jul; 38(7):1022-4. PubMed ID: 7258201
[TBL] [Abstract][Full Text] [Related]
17. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
[TBL] [Abstract][Full Text] [Related]
18. [Successful therapy of salicylate poisoning using glycine and activated charcoal].
Mühlebach S; Steger P; Conen D; Wyss PA
Schweiz Med Wochenschr; 1996 Dec; 126(49):2127-9. PubMed ID: 8999500
[TBL] [Abstract][Full Text] [Related]
19. Desorption of furosemide from charcoal in vitro and in man.
Roivas L; Kivistö KT; Neuvonen PJ
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):365-9. PubMed ID: 7952799
[TBL] [Abstract][Full Text] [Related]
20. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
Brahmi N; Kouraichi N; Thabet H; Amamou M
Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
